 Kelly Sullivan
Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 12 | 2023 | 335 | 2.410 |
Why?
| | Tumor Suppressor Protein p53 | 11 | 2023 | 445 | 2.310 |
Why?
| | Proteome | 2 | 2021 | 339 | 1.050 |
Why?
| | Apoptosis | 14 | 2023 | 2362 | 0.950 |
Why?
| | Liposarcoma | 1 | 2023 | 26 | 0.870 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 5 | 2023 | 56 | 0.810 |
Why?
| | Piperazines | 5 | 2022 | 309 | 0.800 |
Why?
| | Genes, p53 | 2 | 2012 | 61 | 0.790 |
Why?
| | Neoplasms | 8 | 2023 | 2097 | 0.740 |
Why?
| | Transcriptional Activation | 3 | 2022 | 337 | 0.730 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 23 | 0.730 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 31 | 0.730 |
Why?
| | Azetidines | 1 | 2020 | 31 | 0.720 |
Why?
| | Databases, Genetic | 1 | 2021 | 206 | 0.700 |
Why?
| | Transcriptome | 3 | 2021 | 725 | 0.670 |
Why?
| | Interferons | 4 | 2023 | 151 | 0.650 |
Why?
| | Metabolome | 1 | 2021 | 282 | 0.620 |
Why?
| | Tumor Suppressor Proteins | 4 | 2018 | 282 | 0.610 |
Why?
| | GTPase-Activating Proteins | 2 | 2015 | 71 | 0.590 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 2 | 2015 | 63 | 0.580 |
Why?
| | Sulfonamides | 1 | 2020 | 445 | 0.570 |
Why?
| | Hypersensitivity | 1 | 2020 | 252 | 0.570 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1141 | 0.550 |
Why?
| | Protein Kinase Inhibitors | 3 | 2020 | 785 | 0.530 |
Why?
| | Antineoplastic Agents | 3 | 2023 | 1879 | 0.530 |
Why?
| | Caenorhabditis elegans Proteins | 2 | 2015 | 180 | 0.510 |
Why?
| | Isoquinolines | 1 | 2015 | 36 | 0.500 |
Why?
| | Mitochondrial Turnover | 1 | 2015 | 4 | 0.490 |
Why?
| | Immunity, Innate | 2 | 2020 | 720 | 0.490 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1314 | 0.430 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 551 | 0.410 |
Why?
| | Reactive Oxygen Species | 1 | 2015 | 531 | 0.400 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2012 | 67 | 0.390 |
Why?
| | Fibroblasts | 1 | 2016 | 837 | 0.390 |
Why?
| | Patient Selection | 1 | 2015 | 641 | 0.380 |
Why?
| | Imidazoles | 3 | 2020 | 208 | 0.360 |
Why?
| | Interferon-alpha | 3 | 2020 | 186 | 0.360 |
Why?
| | Cerebellar Neoplasms | 2 | 2022 | 130 | 0.340 |
Why?
| | Medulloblastoma | 2 | 2022 | 172 | 0.340 |
Why?
| | Membrane Proteins | 1 | 2015 | 1018 | 0.320 |
Why?
| | Gene Expression Profiling | 4 | 2021 | 1518 | 0.310 |
Why?
| | Trisomy | 2 | 2019 | 68 | 0.300 |
Why?
| | Biomarkers | 3 | 2022 | 3408 | 0.290 |
Why?
| | Inflammation | 1 | 2017 | 2477 | 0.280 |
Why?
| | HCT116 Cells | 3 | 2017 | 70 | 0.280 |
Why?
| | Humans | 32 | 2023 | 114623 | 0.260 |
Why?
| | Autophagy | 2 | 2018 | 233 | 0.230 |
Why?
| | Cell Proliferation | 6 | 2023 | 2186 | 0.230 |
Why?
| | Proto-Oncogene Proteins | 4 | 2023 | 608 | 0.220 |
Why?
| | Animals | 14 | 2023 | 31694 | 0.220 |
Why?
| | Receptors, Interferon | 2 | 2023 | 47 | 0.220 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 18 | 0.220 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 40 | 0.220 |
Why?
| | Glutamine | 1 | 2023 | 91 | 0.220 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 14 | 0.210 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 133 | 0.210 |
Why?
| | Mice | 9 | 2023 | 14860 | 0.210 |
Why?
| | Cell Line, Tumor | 6 | 2023 | 2710 | 0.210 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2015 | 398 | 0.210 |
Why?
| | Centrosome | 2 | 2023 | 59 | 0.200 |
Why?
| | Nuclear Proteins | 3 | 2017 | 591 | 0.200 |
Why?
| | Purines | 2 | 2020 | 159 | 0.200 |
Why?
| | Hedgehog Proteins | 2 | 2023 | 172 | 0.190 |
Why?
| | Cilia | 2 | 2023 | 162 | 0.190 |
Why?
| | Cell Death | 1 | 2022 | 322 | 0.190 |
Why?
| | Pyrazoles | 2 | 2022 | 362 | 0.190 |
Why?
| | Datasets as Topic | 1 | 2021 | 99 | 0.180 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.180 |
Why?
| | Seroconversion | 1 | 2021 | 45 | 0.180 |
Why?
| | Signal Transduction | 5 | 2023 | 4509 | 0.180 |
Why?
| | Cell Line | 5 | 2021 | 2635 | 0.180 |
Why?
| | Data Mining | 1 | 2021 | 100 | 0.180 |
Why?
| | RNA Helicases | 1 | 2020 | 20 | 0.170 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1313 | 0.170 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 167 | 0.170 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2019 | 31 | 0.170 |
Why?
| | DNA Repair | 1 | 2021 | 184 | 0.170 |
Why?
| | Metabolomics | 2 | 2021 | 521 | 0.170 |
Why?
| | Protein Domains | 2 | 2017 | 207 | 0.170 |
Why?
| | Proteomics | 2 | 2023 | 836 | 0.160 |
Why?
| | Kynurenine | 1 | 2019 | 81 | 0.160 |
Why?
| | Complement System Proteins | 2 | 2021 | 282 | 0.160 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 13 | 0.150 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 385 | 0.150 |
Why?
| | Autoimmunity | 2 | 2023 | 813 | 0.150 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 49 | 0.150 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2017 | 38 | 0.150 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 383 | 0.140 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 171 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2021 | 3003 | 0.140 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 3 | 0.140 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 344 | 0.140 |
Why?
| | Cell Cycle Checkpoints | 2 | 2020 | 84 | 0.140 |
Why?
| | Caspases | 2 | 2015 | 245 | 0.140 |
Why?
| | Antigens | 1 | 2018 | 318 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 671 | 0.140 |
Why?
| | Histidine Kinase | 1 | 2016 | 33 | 0.140 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 151 | 0.130 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 4689 | 0.130 |
Why?
| | Proteolysis | 1 | 2017 | 142 | 0.130 |
Why?
| | Down-Regulation | 2 | 2017 | 594 | 0.130 |
Why?
| | Young Adult | 3 | 2021 | 10455 | 0.130 |
Why?
| | Genomics | 1 | 2021 | 635 | 0.130 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 215 | 0.130 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 153 | 0.130 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2015 | 10 | 0.120 |
Why?
| | Pyrones | 1 | 2015 | 9 | 0.120 |
Why?
| | Caspase 8 | 1 | 2015 | 43 | 0.120 |
Why?
| | Cells, Cultured | 3 | 2018 | 3881 | 0.120 |
Why?
| | bcl-2-Associated X Protein | 1 | 2015 | 45 | 0.120 |
Why?
| | Transcription Factors | 2 | 2022 | 1528 | 0.120 |
Why?
| | Azepines | 1 | 2015 | 75 | 0.120 |
Why?
| | Repressor Proteins | 1 | 2017 | 366 | 0.120 |
Why?
| | Carrier Proteins | 1 | 2018 | 695 | 0.120 |
Why?
| | Heat-Shock Proteins | 1 | 2015 | 113 | 0.120 |
Why?
| | Female | 8 | 2021 | 59466 | 0.120 |
Why?
| | Morpholines | 1 | 2015 | 102 | 0.110 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 353 | 0.110 |
Why?
| | Fluorouracil | 1 | 2015 | 152 | 0.110 |
Why?
| | Aminobenzoates | 1 | 2013 | 7 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 213 | 0.110 |
Why?
| | Cytokines | 2 | 2019 | 1840 | 0.110 |
Why?
| | Monocytes | 1 | 2016 | 502 | 0.110 |
Why?
| | Naphthalenes | 1 | 2013 | 38 | 0.110 |
Why?
| | Male | 6 | 2021 | 55554 | 0.110 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 577 | 0.110 |
Why?
| | RNA Interference | 1 | 2015 | 433 | 0.110 |
Why?
| | Liver | 1 | 2020 | 1634 | 0.110 |
Why?
| | Enzyme Activation | 1 | 2015 | 785 | 0.100 |
Why?
| | Ligands | 1 | 2015 | 561 | 0.100 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2015 | 157 | 0.100 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 535 | 0.100 |
Why?
| | Genes, Synthetic | 1 | 2012 | 14 | 0.100 |
Why?
| | Genes, Lethal | 1 | 2012 | 26 | 0.100 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 796 | 0.100 |
Why?
| | Pyrimidines | 1 | 2015 | 376 | 0.100 |
Why?
| | Chronic Disease | 1 | 2017 | 1578 | 0.100 |
Why?
| | Adult | 4 | 2021 | 30528 | 0.100 |
Why?
| | Caenorhabditis elegans | 1 | 2014 | 268 | 0.100 |
Why?
| | Telomerase | 1 | 2013 | 206 | 0.100 |
Why?
| | Lipids | 1 | 2015 | 580 | 0.090 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 1982 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2319 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2785 | 0.090 |
Why?
| | Cell Cycle | 1 | 2012 | 542 | 0.080 |
Why?
| | Mitochondria | 1 | 2015 | 747 | 0.080 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1736 | 0.080 |
Why?
| | Mutation | 2 | 2015 | 3344 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2018 | 1862 | 0.070 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2177 | 0.060 |
Why?
| | Infant | 1 | 2017 | 7959 | 0.060 |
Why?
| | Middle Aged | 2 | 2021 | 26719 | 0.060 |
Why?
| | Child, Preschool | 1 | 2017 | 9108 | 0.060 |
Why?
| | Phenotype | 2 | 2023 | 2796 | 0.060 |
Why?
| | Glutamates | 1 | 2023 | 57 | 0.060 |
Why?
| | Proline | 1 | 2023 | 72 | 0.050 |
Why?
| | Child | 2 | 2022 | 18404 | 0.050 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 23 | 0.050 |
Why?
| | Centrioles | 1 | 2023 | 35 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 77 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 1889 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 41 | 0.050 |
Why?
| | Binding Sites | 2 | 2014 | 1168 | 0.050 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 27 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2023 | 3531 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 138 | 0.050 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 286 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 240 | 0.040 |
Why?
| | Polyribosomes | 1 | 2020 | 22 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 115 | 0.040 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 29 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2021 | 171 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 7 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 19 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 44 | 0.040 |
Why?
| | Adolescent | 1 | 2017 | 17831 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 129 | 0.040 |
Why?
| | Gene Silencing | 1 | 2020 | 171 | 0.040 |
Why?
| | Phosphorylation | 1 | 2022 | 1569 | 0.040 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 73 | 0.040 |
Why?
| | Cellular Senescence | 1 | 2019 | 152 | 0.040 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 31 | 0.040 |
Why?
| | Complement Activation | 1 | 2021 | 340 | 0.040 |
Why?
| | Hexokinase | 1 | 2017 | 10 | 0.040 |
Why?
| | Glucose Transporter Type 3 | 1 | 2017 | 11 | 0.040 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2017 | 30 | 0.040 |
Why?
| | Cell Lineage | 1 | 2019 | 309 | 0.040 |
Why?
| | Deoxyglucose | 1 | 2017 | 43 | 0.040 |
Why?
| | Homeostasis | 1 | 2021 | 573 | 0.040 |
Why?
| | MCF-7 Cells | 1 | 2017 | 105 | 0.040 |
Why?
| | Gene Editing | 1 | 2017 | 57 | 0.040 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 9 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 384 | 0.030 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 20 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 339 | 0.030 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2017 | 111 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 345 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2017 | 220 | 0.030 |
Why?
| | Glycolysis | 1 | 2017 | 226 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1448 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2019 | 719 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 849 | 0.030 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 62 | 0.030 |
Why?
| | Base Sequence | 1 | 2020 | 2114 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1083 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1037 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 96 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 14 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 51 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 687 | 0.030 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2014 | 38 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1421 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 868 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1620 | 0.030 |
Why?
| | Serine Proteases | 1 | 2013 | 14 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 805 | 0.030 |
Why?
| | Protein Transport | 1 | 2014 | 395 | 0.030 |
Why?
| | Chromatin | 1 | 2016 | 428 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2020 | 2552 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 329 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 698 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2019 | 1700 | 0.030 |
Why?
| | Telomere-Binding Proteins | 1 | 2013 | 88 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2017 | 966 | 0.030 |
Why?
| | Hospitalization | 1 | 2021 | 1749 | 0.030 |
Why?
| | HeLa Cells | 1 | 2013 | 562 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1040 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1020 | 0.020 |
Why?
| | RNA | 1 | 2014 | 809 | 0.020 |
Why?
|
|
Sullivan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|